James Shin
Stock Analyst at Deutsche Bank
(2.77)
# 1,916
Out of 5,182 analysts
25
Total ratings
58.33%
Success rate
23.28%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STRO Sutro Biopharma | Maintains: Buy | $51 → $55 | $34.87 | +57.73% | 2 | Mar 25, 2026 | |
| LLY Eli Lilly and Company | Maintains: Buy | $1,200 → $1,285 | $874.00 | +47.03% | 6 | Feb 9, 2026 | |
| MRK Merck & Co. | Maintains: Hold | $110 → $111 | $110.03 | +0.88% | 3 | Nov 18, 2025 | |
| IMTX Immatics | Initiates: Buy | $10 | $11.59 | -13.72% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $129.26 | -7.16% | 2 | Feb 18, 2025 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $339.57 | -10.18% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $97.74 | -38.61% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $58.26 | -22.76% | 3 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $23.56 | +154.67% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $197.69 | -24.12% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $800 | $731.77 | +9.32% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.48 | +575.68% | 1 | Nov 9, 2023 |
Sutro Biopharma
Mar 25, 2026
Maintains: Buy
Price Target: $51 → $55
Current: $34.87
Upside: +57.73%
Eli Lilly and Company
Feb 9, 2026
Maintains: Buy
Price Target: $1,200 → $1,285
Current: $874.00
Upside: +47.03%
Merck & Co.
Nov 18, 2025
Maintains: Hold
Price Target: $110 → $111
Current: $110.03
Upside: +0.88%
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $11.59
Upside: -13.72%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $129.26
Upside: -7.16%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $339.57
Upside: -10.18%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $97.74
Upside: -38.61%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $58.26
Upside: -22.76%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $23.56
Upside: +154.67%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $197.69
Upside: -24.12%
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $731.77
Upside: +9.32%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.48
Upside: +575.68%